Back to Search
Start Over
Warner-Lambert Drug Avoids Disaster Before FDA Panel but Sales May Suffer.
- Source :
-
Wall Street Journal - Eastern Edition . 03/29/99, Vol. 233 Issue 60, pB6. 0p. - Publication Year :
- 1999
-
Abstract
- Focuses on the hearing conducted by the United States Food and Drug Administration on Warner-Lambert Company's diabetes drug called Rezulin. Side effects of the drug; Expected decline of sales.
- Subjects :
- *DRUG side effects
*TREATMENT of diabetes
Subjects
Details
- Language :
- English
- ISSN :
- 00999660
- Volume :
- 233
- Issue :
- 60
- Database :
- Academic Search Index
- Journal :
- Wall Street Journal - Eastern Edition
- Publication Type :
- News
- Accession number :
- 1704834